What is ServRx?
ServRx specializes in providing customized electronic solutions for the processing of Workers Compensation prescription claims. Their platform is designed to improve patient care and optimize pharmacy revenue for independent pharmacies, non-pharmacy dispensing sites, and national chains. By ensuring real-time processing and immediate payment confirmation, ServRx empowers pharmacies to manage dispensing and inventory effectively. The company's unique approach, which avoids affiliation with Pharmacy Benefit Managers (PBMs), aims to retain patients within their chosen pharmacy for the entirety of their claims. Services include SureScripts certified E-prescribing and a dedicated, seven-day-a-week help desk, positioning ServRx as a comprehensive solution provider in its niche.
How much funding has ServRx raised?
ServRx has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in ServRx
PPP
Public-Private Partnership
What's next for ServRx?
With the recent influx of capital, ServRx is poised for accelerated growth and further innovation in its service offerings. The large-scale, late-stage funding suggests a focus on scaling operations, expanding market reach, and potentially developing new technological capabilities to further streamline the Workers Compensation claims process. This strategic investment will likely enable ServRx to enhance its platform, deepen its partnerships within the healthcare ecosystem, and solidify its competitive advantage in delivering efficient and reliable prescription processing solutions. The company's emphasis on direct pharmacy support and patient retention indicates a strategy geared towards long-term value creation and market leadership.
See full ServRx company page
